News
The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...
FDA announced it has awarded 510(k) clearance for expanded indications of the Masimo O3 Regional Oximetry System to include various delta hemoglobin parameters (ΔcHb, ΔHHb and ΔO 2 Hb) to display ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback